Skip to main content

Market Overview

Morning Market Gainers

Share:

Cytokinetics, Incorporated (NASDAQ: CYTK) shares climbed 18.46% to $7.69 on Q4 results. Cytokinetics reported Q4 earnings of $8.4 million.

CyberArk Software, Ltd. (NASDAQ: CYBR) shares surged 17.57% to $53.72 after the company posted Q4 revenue growth of 80% and offered an outlook for the current period above expectations.

King Digital Entertainment plc(NYSE: KING) shares jumped 15.06% to $16.96 after the company reported financial results Thursday for the fourth quarter ended December 31, 2014 and beat expectations.

Freescale Semiconductor, Ltd. (NYSE: FSL) gained 11.30% to $38.62 following NY Post report that the company may be exploring sale.

j2 Global, Inc. (NASDAQ: JCOM) shares jumped 10.72% to $65.92 on better-than-expected Q4 results.

Columbia Sportswear Company (NASDAQ: COLM) shares surged 10.14% to $48.01 after the company reported upbeat Q4 earnings and issued a strong FY15 earnings forecast.

Goodrich Petroleum Corp. (NYSE: GDP) gained 10.03% to $3.62. Susquehanna raised stake in the company from 1.65% to 4.1%.

FX Energy Inc. (NASDAQ: FXEN) shares climbed 7.88% to $2.04 after jumping 35.00% on Thursday.

Rocky Brands, Inc. (NASDAQ: RCKY) shares rose 7.59% to $15.17. Rocky Brands reported Q4 earnings of $0.59 per share on revenue of $78.9 million.

Energy XXI Ltd. (NASDAQ: EXXI) shares gained 4.46% to $3.74 after rising 7.19% on Thursday.

CBS Corporation (NYSE: CBS) shares surged 3.98% to $60.07 after the company reported strong revenue and earnings for the fourth quarter.

 

Related Articles (CYTK + CYBR)

View Comments and Join the Discussion!

Posted-In: Market GainersNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com